14 June 2018 EMA/409662/2018 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: acitretin

Procedure no.: PSUSA/00000051/201710

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Acicutan 10 mg

NL/H/1958/001/DC

81208.00.00

DERMAPHARM AG

DE

NL/H/1958/002/DC

81209.00.00

DERMAPHARM AG

DE

NL/H/1958/001

18728

SUN-FARM SP. Z.O.O.

PL

NL/H/1958/002

18729

SUN-FARM SP. Z.O.O.

PL

DK/H/2552/001

56275

ORIFARM GENERICS A/S

DK

DK/H/2552/002

56280

ORIFARM GENERICS A/S

DK

NL/H/1959/001

PL 06831/0251

GENUS PHARMACEUTICALS

UK

Hartkapseln Acicutan 25 mg Hartkapseln Acitren, 10 mg, kapsułki twarde Acitren, 25 mg, kapsułki twarde Acitretin "Orifarm", hårde kapsler Acitretin "Orifarm", hårde kapsler Acitretin 10 mg Capsules

LIMITED Acitretin 10mg Capsules

not available

PL 20117/0265

MORNINGSIDE HEALTHCARE

UK

LTD Acitretin 25 mg Capsules

NL/H/1959/002

PL 06831/0252

GENUS PHARMACEUTICALS

UK

LIMITED Acitretin 25mg Capsules

not available

PL 20117/0266

MORNINGSIDE HEALTHCARE

UK

LTD

List of nationally authorised medicinal products EMA/409662/2018

Page 2/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Acitretin Orifarm 10 mg

DK/H/2552/001

53202

ORIFARM GENERICS A/S

SE

DK/H/2552/001

33560

ORIFARM GENERICS A/S

FI

DK/H/2552/001

15-10784

ORIFARM GENERICS A/S

NO

DK/H/2552/002

53203

ORIFARM GENERICS A/S

SE

DK/H/2552/002

33561

ORIFARM GENERICS A/S

FI

DK/H/2552/002

15-10785

ORIFARM GENERICS A/S

NO

NL/H/1961/001

74.727

INDUSTRIAL FARMACEUTICA

ES

hårda kapslar Acitretin Orifarm 10 mg kapseli, kova Acitretin Orifarm 10 mg kapsler, harde Acitretin Orifarm 25 mg hårda kapslar Acitretin Orifarm 25 mg kapseli, kova Acitretin Orifarm 25 mg kapsler, harde Acitretina IFC 10 mg cápsulas duras EFG Acitretina IFC 25 mg

CANTABRIA, S.A. NL/H/1961/002

74.726

cápsulas duras EFG Acitretine CF 10 mg,

INDUSTRIAL FARMACEUTICA

ES

CANTABRIA, S.A. NL/H/1959/001

RVG 107065

CENTRAFARM B.V.

NL

capsules

List of nationally authorised medicinal products EMA/409662/2018

Page 3/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Acitretine CF 25 mg,

NL/H/1959/002

RVG 107066

CENTRAFARM B.V.

NL

NL/H/1961/001

RVG 107057

INDUSTRIAL FARMACEUTICA

NL

capsules Acitretine IFC 10 mg capsules Acitretine IFC 25 mg

CANTABRIA, S.A. NL/H/1961/002

RVG 107058

capsules

INDUSTRIAL FARMACEUTICA

NL

CANTABRIA, S.A.

Keracutan 10 mg Kapseln

not available

1-31432

PELPHARMA HANDELS GMBH

AT

Keracutan 25 mg Kapseln

not available

1-31433

PELPHARMA HANDELS GMBH

AT

Keraderm 10 mg

NL/H/1958/001

RVG 107061

DERMAPHARM AG

NL

NL/H/1958/002

RVG 107062

DERMAPHARM AG

NL

Neotigason 10mg

not available

46/0661/95-S

ACTAVIS GROUP PTC EHF.

SK

Neotigason 25 mg tvrdé

not available

46/0263/15-S

ACTAVIS GROUP PTC EHF.

SK

capsules Keraderm 25 mg capsules

kapsuly

List of nationally authorised medicinal products EMA/409662/2018

Page 4/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Neotigason 10

not available

22414.00.00

PUREN PHARMA GMBH & CO.

DE

KG Neotigason 10 mg

not available

8756403

Cápsulas Neotigason 10 mg

not available

8756411

not available

8756403

PT

AUROVITAS UNIPESSOAL,

PT

LDA. not available

8756411

Cápsulas Neotigason 10 mg

AUROVITAS UNIPESSOAL, LDA.

Cápsulas Neotigason 10 mg

PT

LDA.

Cápsulas Neotigason 10 mg

AUROVITAS UNIPESSOAL,

AUROVITAS UNIPESSOAL,

PT

LDA. not available

9699/2017/01

ACTAVIS GROUP PTC EHF.

RO

not available

PA 1380/050/001

ACTAVIS GROUP PTC EHF.

IE

not available

96-0595

ACTAVIS GROUP PTC EHF.

LV

not available

BE144706

AUROBINDO PHARMA B.V.

BE

capsule Neotigason 10 mg capsules NEOTIGASON 10 mg cietās kapsulas Neotigason 10 mg gélules

List of nationally authorised medicinal products EMA/409662/2018

Page 5/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Neotigason 10 mg gélules

not available

0147999

AUROBINDO PHARMA B.V.

LU

Neotigason 10 mg hårda

not available

12742

ACTAVIS GROUP PTC EHF.

SE

not available

BE144706

AUROBINDO PHARMA B.V.

BE

not available

BE144706

AUROBINDO PHARMA B.V.

BE

not available

0147999

AUROBINDO PHARMA B.V.

LU

not available

10116

ACTAVIS GROUP PTC EHF.

FI

not available

1-18708

ACTAVIS GROUP PTC EHF.

AT

not available

7759

ACTAVIS GROUP PTC EHF.

NO

not available

OGYI-T-4469/01

ACTAVIS GROUP PTC EHF.

HU

kapslar Neotigason 10 mg harde capsules Neotigason 10 mg Hartkapseln Neotigason 10 mg Hartkapseln Neotigason 10 mg kapseli, kova NEOTIGASON 10 mg Kapseln Neotigason 10 mg kapsler, harde Neotigason 10 mg kemény kapszula

List of nationally authorised medicinal products EMA/409662/2018

Page 6/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Neotigason 10 mg

not available

LT/1/94/0419/001

ACTAVIS GROUP PTC EHF.

LT

not available

083694

ACTAVIS GROUP PTC EHF.

EE

not available

H/96/01103/001

ACTAVIS GROUP PTC EHF.

SI

not available

HR-H-047281874

ACTAVIS GROUP PTC EHF.

HR

not available

46/145/95-A/C

ACTAVIS GROUP PTC EHF.

CZ

not available

RVG 13103

AUROBINDO PHARMA B.V.

NL

not available

MA628/04101

ACTAVIS GROUP PTC EHF.

MT

not available

PL 30306/0096

ACTAVIS GROUP PTC EHF.

UK

not available

870227

ACTAVIS GROUP PTC EHF.

IS

kietosios kapsulės Neotigason 10 mg kõvakapslid NEOTIGASON 10 mg trde kapsule Neotigason 10 mg tvrde kapsule Neotigason 10 mg Tvrdé tobolky Neotigason 10 mg, capsules Neotigason 10mg capsules Neotigason 10mg Capsules Neotigason 10mg hörð hylki

List of nationally authorised medicinal products EMA/409662/2018

Page 7/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Neotigason 25

not available

22414.01.00

PUREN PHARMA GMBH & CO.

DE

KG Neotigason 25 mg

not available

8756437

Cápsulas Neotigason 25 mg

not available

8756429

not available

8756437

PT

AUROVITAS UNIPESSOAL,

PT

LDA. not available

8756429

Cápsulas Neotigason 25 mg

AUROVITAS UNIPESSOAL, LDA.

Cápsulas Neotigason 25 mg

PT

LDA.

Cápsulas Neotigason 25 mg

AUROVITAS UNIPESSOAL,

AUROVITAS UNIPESSOAL,

PT

LDA. not available

PA 1380/050/002

ACTAVIS GROUP PTC EHF.

IE

Neotigason 25 mg gélules

not available

BE144602

AUROBINDO PHARMA B.V.

BE

Neotigason 25 mg gélules

not available

0148013

AUROBINDO PHARMA B.V.

LU

Neotigason 25 mg hårda

not available

12743

ACTAVIS GROUP PTC EHF.

SE

capsules

kapslar

List of nationally authorised medicinal products EMA/409662/2018

Page 8/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Neotigason 25 mg harde

not available

BE144602

AUROBINDO PHARMA B.V.

BE

not available

BE144602

AUROBINDO PHARMA B.V.

BE

not available

0148013

AUROBINDO PHARMA B.V.

LU

not available

10117

ACTAVIS GROUP PTC EHF.

FI

not available

1-18709

ACTAVIS GROUP PTC EHF.

AT

not available

7760

ACTAVIS GROUP PTC EHF.

NO

not available

OGYI-T-4469/02

ACTAVIS GROUP PTC EHF.

HU

not available

H/96/01103/002

ACTAVIS GROUP PTC EHF.

SI

not available

HR-H-770001325

ACTAVIS GROUP PTC EHF.

HR

capsules Neotigason 25 mg Hartkapseln Neotigason 25 mg Hartkapseln Neotigason 25 mg kapseli, kova Neotigason 25 mg Kapseln Neotigason 25 mg kapsler, harde Neotigason 25 mg kemény kapszula NEOTIGASON 25 mg trde kapsule Neotigason 25 mg tvrde kapsule

List of nationally authorised medicinal products EMA/409662/2018

Page 9/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Neotigason 25 mg Tvrdé

not available

46/145/95-B/C

ACTAVIS GROUP PTC EHF.

CZ

not available

RVG 13104

AUROBINDO PHARMA B.V.

NL

not available

MA628/04102

ACTAVIS GROUP PTC EHF.

MT

not available

PL 30306/0097

ACTAVIS GROUP PTC EHF.

UK

not available

870226

ACTAVIS GROUP PTC EHF.

IS

not available

R/6970

ACTAVIS GROUP PTC EHF.

PL

not available

R/6969

ACTAVIS GROUP PTC EHF.

PL

not available

13124

ACTAVIS GROUP PTC EHF.

DK

not available

13125

ACTAVIS GROUP PTC EHF.

DK

tobolky Neotigason 25 mg, capsules Neotigason 25mg capsules Neotigason 25mg Capsules Neotigason 25mg hörð hylki Neotigason, 10 mg, kapsułki Neotigason, 25 mg, kapsułki Neotigason, hårde kapsler Neotigason, hårde kapsler

List of nationally authorised medicinal products EMA/409662/2018

Page 10/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

NEOTIGASON®

not available

60863/12/11-11-2013

ACTAVIS GROUP PTC EHF.

GR

NEOTIGASON®

not available

85248/11-11-2013

ACTAVIS GROUP PTC EHF.

GR

Regioderm 10 mg capsule

NL/H/1960/001

042668018

REGIOMEDICA GMBH

IT

Regioderm 10 mg

NL/H/1960/001

RVG 107059

REGIOMEDICA GMBH

NL

Regioderm 25 mg capsule

NL/H/1960/002

042668020

REGIOMEDICA GMBH

IT

Regioderm 25 mg

NL/H/1960/002

RVG 107060

REGIOMEDICA GMBH

NL

not available

NL 15451

ARROW GENERIQUES

FR

not available

NL : 15452

ARROW GENERIQUES

FR

NL/H/1961/001

041619014

DIFA COOPER S.P.A.

IT

capsules

capsules SORIATANE 10 mg, gélule SORIATANE 25 mg, gélule Zorias 10 mg capsule

List of nationally authorised medicinal products EMA/409662/2018

Page 11/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Zorias 10 mg capsule

NL/H/1961/001

041619026

DIFA COOPER S.P.A.

IT

Zorias 10 mg capsule

NL/H/1961/001

041619053

DIFA COOPER S.P.A.

IT

Zorias 25 mg capsule

NL/H/1961/002

041619038

DIFA COOPER S.P.A.

IT

Zorias 25 mg capsule

NL/H/1961/002

041619040

DIFA COOPER S.P.A.

IT

Zorias 25 mg capsule

NL/H/1961/002

041619065

DIFA COOPER S.P.A.

IT

НЕОТИГАЗОН 10 MG

not available

20010476

ACTAVIS GROUP PTC EHF.

BG

ТВЪРДИ КАПСУЛИ

List of nationally authorised medicinal products EMA/409662/2018

Page 12/12

PSUSA/00000051/201710 - European Medicines Agency - Europa EU

Jun 14, 2018 - MT. Neotigason 10mg. Capsules not available. PL 30306/0096. ACTAVIS GROUP PTC EHF. UK. Neotigason 10mg hörð hylki not available.

132KB Sizes 13 Downloads 151 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...